aluates Reports

$ 0.0

Automative

Global Infectious Disease Testing Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Othe-4U222

Global Infectious Disease Testing Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Infectious Disease Testing Market Research Report 2025

Code: QYRE-Othe-4U222

Report

September 2025

Pages:107

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Infectious Disease Testing Market Size

The global market for Infectious Disease Testing was valued at US$ 17700 million in the year 2024 and is projected to reach a revised size of US$ 22440 million by 2031, growing at a CAGR of 3.5% during the forecast period.

Infectious Disease Testing Market

In hospitals, infectious disease specialists help ensure the timely diagnosis and treatment of acute infections by recommending the appropriate diagnostic tests to identify the source of the infection and by recommending the appropriate antibiotic to treat the infection.

Biochemical tests used in the identification of infectious agents include the detection of metabolic or enzymatic products characteristic of a particular infectious agent. Since bacteria ferment carbohydrates in patterns characteristic of their genus and species, the detection of fermentation products is commonly used in bacterial identification. Acids, alcohols and gases are usually detected in these tests when bacteria are grown in selective liquid or solid media.

This report aims to provide a comprehensive presentation of the global market for Infectious Disease Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease Testing.

The Infectious Disease Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Infectious Disease Testing market comprehensively. Regional market sizes, concerning products by Technology, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Infectious Disease Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Technology, by Application, and by regions.

Market Segmentation

Scope of Infectious Disease Testing Market Report

Report Metric	Details
Report Name	Infectious Disease Testing Market
Accounted market size in year	US$ 17700 million
Forecasted market size in 2031	US$ 22440 million
CAGR	3.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Technology	Immunodiagnostics Clinical Microbiology PCR INAAT DNA Sequencing & NGS DNA Microarrays Other
Segment by Application	Hospitals/Clinical Laboratories Reference Laboratories Academic/Research Institutes Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott Diagnostics, Abbott, Beckman Coulter Diagnostics, Roche, Siemens Healthcare, Abaxis, Acon Laboratories, Avioq, BD, Bio-Rad Laboratories, Cavidi, Cepheid, Chembio Diagnostic Systems, Clarity Diagnostics, EMD Millipore, Epitope Diagnostic, Gold Standard Diagnostics, Hologic, Immunetics, InBios International, Life Technologies, Maxim Biomedical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Technology, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infectious Disease Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Technology, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Infectious Disease Testing Market growing?

Ans: The Infectious Disease Testing Market witnessing a CAGR of 3.5% during the forecast period 2025-2031.

What is the Infectious Disease Testing Market size in 2031?

Ans: The Infectious Disease Testing Market size in 2031 will be US$ 22440 million.

Who are the main players in the Infectious Disease Testing Market report?

Ans: The main players in the Infectious Disease Testing Market are Abbott Diagnostics, Abbott, Beckman Coulter Diagnostics, Roche, Siemens Healthcare, Abaxis, Acon Laboratories, Avioq, BD, Bio-Rad Laboratories, Cavidi, Cepheid, Chembio Diagnostic Systems, Clarity Diagnostics, EMD Millipore, Epitope Diagnostic, Gold Standard Diagnostics, Hologic, Immunetics, InBios International, Life Technologies, Maxim Biomedical

What are the Application segmentation covered in the Infectious Disease Testing Market report?

Ans: The Applications covered in the Infectious Disease Testing Market report are Hospitals/Clinical Laboratories, Reference Laboratories, Academic/Research Institutes, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Technology

1.2.1 Global Infectious Disease Testing Market Size Growth Rate by Technology: 2020 VS 2024 VS 2031

1.2.2 Immunodiagnostics

1.2.3 Clinical Microbiology

1.2.4 PCR

1.2.5 INAAT

1.2.6 DNA Sequencing & NGS

1.2.7 DNA Microarrays

1.2.8 Other

1.3 Market by Application

1.3.1 Global Infectious Disease Testing Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals/Clinical Laboratories

1.3.3 Reference Laboratories

1.3.4 Academic/Research Institutes

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Infectious Disease Testing Market Perspective (2020-2031)

2.2 Global Infectious Disease Testing Growth Trends by Region

2.2.1 Global Infectious Disease Testing Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Infectious Disease Testing Historic Market Size by Region (2020-2025)

2.2.3 Infectious Disease Testing Forecasted Market Size by Region (2026-2031)

2.3 Infectious Disease Testing Market Dynamics

2.3.1 Infectious Disease Testing Industry Trends

2.3.2 Infectious Disease Testing Market Drivers

2.3.3 Infectious Disease Testing Market Challenges

2.3.4 Infectious Disease Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Infectious Disease Testing Players by Revenue

3.1.1 Global Top Infectious Disease Testing Players by Revenue (2020-2025)

3.1.2 Global Infectious Disease Testing Revenue Market Share by Players (2020-2025)

3.2 Global Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Infectious Disease Testing Revenue

3.4 Global Infectious Disease Testing Market Concentration Ratio

3.4.1 Global Infectious Disease Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Testing Revenue in 2024

3.5 Global Key Players of Infectious Disease Testing Head office and Area Served

3.6 Global Key Players of Infectious Disease Testing, Product and Application

3.7 Global Key Players of Infectious Disease Testing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Infectious Disease Testing Breakdown Data by Technology

4.1 Global Infectious Disease Testing Historic Market Size by Technology (2020-2025)

4.2 Global Infectious Disease Testing Forecasted Market Size by Technology (2026-2031)

5 Infectious Disease Testing Breakdown Data by Application

5.1 Global Infectious Disease Testing Historic Market Size by Application (2020-2025)

5.2 Global Infectious Disease Testing Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Infectious Disease Testing Market Size (2020-2031)

6.2 North America Infectious Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Infectious Disease Testing Market Size by Country (2020-2025)

6.4 North America Infectious Disease Testing Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Infectious Disease Testing Market Size (2020-2031)

7.2 Europe Infectious Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Infectious Disease Testing Market Size by Country (2020-2025)

7.4 Europe Infectious Disease Testing Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Infectious Disease Testing Market Size (2020-2031)

8.2 Asia-Pacific Infectious Disease Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Infectious Disease Testing Market Size by Region (2020-2025)

8.4 Asia-Pacific Infectious Disease Testing Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Infectious Disease Testing Market Size (2020-2031)

9.2 Latin America Infectious Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Infectious Disease Testing Market Size by Country (2020-2025)

9.4 Latin America Infectious Disease Testing Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Infectious Disease Testing Market Size (2020-2031)

10.2 Middle East & Africa Infectious Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Infectious Disease Testing Market Size by Country (2020-2025)

10.4 Middle East & Africa Infectious Disease Testing Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott Diagnostics

11.1.1 Abbott Diagnostics Company Details

11.1.2 Abbott Diagnostics Business Overview

11.1.3 Abbott Diagnostics Infectious Disease Testing Introduction

11.1.4 Abbott Diagnostics Revenue in Infectious Disease Testing Business (2020-2025)

11.1.5 Abbott Diagnostics Recent Development

11.2 Abbott

11.2.1 Abbott Company Details

11.2.2 Abbott Business Overview

11.2.3 Abbott Infectious Disease Testing Introduction

11.2.4 Abbott Revenue in Infectious Disease Testing Business (2020-2025)

11.2.5 Abbott Recent Development

11.3 Beckman Coulter Diagnostics

11.3.1 Beckman Coulter Diagnostics Company Details

11.3.2 Beckman Coulter Diagnostics Business Overview

11.3.3 Beckman Coulter Diagnostics Infectious Disease Testing Introduction

11.3.4 Beckman Coulter Diagnostics Revenue in Infectious Disease Testing Business (2020-2025)

11.3.5 Beckman Coulter Diagnostics Recent Development

11.4 Roche

11.4.1 Roche Company Details

11.4.2 Roche Business Overview

11.4.3 Roche Infectious Disease Testing Introduction

11.4.4 Roche Revenue in Infectious Disease Testing Business (2020-2025)

11.4.5 Roche Recent Development

11.5 Siemens Healthcare

11.5.1 Siemens Healthcare Company Details

11.5.2 Siemens Healthcare Business Overview

11.5.3 Siemens Healthcare Infectious Disease Testing Introduction

11.5.4 Siemens Healthcare Revenue in Infectious Disease Testing Business (2020-2025)

11.5.5 Siemens Healthcare Recent Development

11.6 Abaxis

11.6.1 Abaxis Company Details

11.6.2 Abaxis Business Overview

11.6.3 Abaxis Infectious Disease Testing Introduction

11.6.4 Abaxis Revenue in Infectious Disease Testing Business (2020-2025)

11.6.5 Abaxis Recent Development

11.7 Acon Laboratories

11.7.1 Acon Laboratories Company Details

11.7.2 Acon Laboratories Business Overview

11.7.3 Acon Laboratories Infectious Disease Testing Introduction

11.7.4 Acon Laboratories Revenue in Infectious Disease Testing Business (2020-2025)

11.7.5 Acon Laboratories Recent Development

11.8 Avioq

11.8.1 Avioq Company Details

11.8.2 Avioq Business Overview

11.8.3 Avioq Infectious Disease Testing Introduction

11.8.4 Avioq Revenue in Infectious Disease Testing Business (2020-2025)

11.8.5 Avioq Recent Development

11.9 BD

11.9.1 BD Company Details

11.9.2 BD Business Overview

11.9.3 BD Infectious Disease Testing Introduction

11.9.4 BD Revenue in Infectious Disease Testing Business (2020-2025)

11.9.5 BD Recent Development

11.10 Bio-Rad Laboratories

11.10.1 Bio-Rad Laboratories Company Details

11.10.2 Bio-Rad Laboratories Business Overview

11.10.3 Bio-Rad Laboratories Infectious Disease Testing Introduction

11.10.4 Bio-Rad Laboratories Revenue in Infectious Disease Testing Business (2020-2025)

11.10.5 Bio-Rad Laboratories Recent Development

11.11 Cavidi

11.11.1 Cavidi Company Details

11.11.2 Cavidi Business Overview

11.11.3 Cavidi Infectious Disease Testing Introduction

11.11.4 Cavidi Revenue in Infectious Disease Testing Business (2020-2025)

11.11.5 Cavidi Recent Development

11.12 Cepheid

11.12.1 Cepheid Company Details

11.12.2 Cepheid Business Overview

11.12.3 Cepheid Infectious Disease Testing Introduction

11.12.4 Cepheid Revenue in Infectious Disease Testing Business (2020-2025)

11.12.5 Cepheid Recent Development

11.13 Chembio Diagnostic Systems

11.13.1 Chembio Diagnostic Systems Company Details

11.13.2 Chembio Diagnostic Systems Business Overview

11.13.3 Chembio Diagnostic Systems Infectious Disease Testing Introduction

11.13.4 Chembio Diagnostic Systems Revenue in Infectious Disease Testing Business (2020-2025)

11.13.5 Chembio Diagnostic Systems Recent Development

11.14 Clarity Diagnostics

11.14.1 Clarity Diagnostics Company Details

11.14.2 Clarity Diagnostics Business Overview

11.14.3 Clarity Diagnostics Infectious Disease Testing Introduction

11.14.4 Clarity Diagnostics Revenue in Infectious Disease Testing Business (2020-2025)

11.14.5 Clarity Diagnostics Recent Development

11.15 EMD Millipore

11.15.1 EMD Millipore Company Details

11.15.2 EMD Millipore Business Overview

11.15.3 EMD Millipore Infectious Disease Testing Introduction

11.15.4 EMD Millipore Revenue in Infectious Disease Testing Business (2020-2025)

11.15.5 EMD Millipore Recent Development

11.16 Epitope Diagnostic

11.16.1 Epitope Diagnostic Company Details

11.16.2 Epitope Diagnostic Business Overview

11.16.3 Epitope Diagnostic Infectious Disease Testing Introduction

11.16.4 Epitope Diagnostic Revenue in Infectious Disease Testing Business (2020-2025)

11.16.5 Epitope Diagnostic Recent Development

11.17 Gold Standard Diagnostics

11.17.1 Gold Standard Diagnostics Company Details

11.17.2 Gold Standard Diagnostics Business Overview

11.17.3 Gold Standard Diagnostics Infectious Disease Testing Introduction

11.17.4 Gold Standard Diagnostics Revenue in Infectious Disease Testing Business (2020-2025)

11.17.5 Gold Standard Diagnostics Recent Development

11.18 Hologic

11.18.1 Hologic Company Details

11.18.2 Hologic Business Overview

11.18.3 Hologic Infectious Disease Testing Introduction

11.18.4 Hologic Revenue in Infectious Disease Testing Business (2020-2025)

11.18.5 Hologic Recent Development

11.19 Immunetics

11.19.1 Immunetics Company Details

11.19.2 Immunetics Business Overview

11.19.3 Immunetics Infectious Disease Testing Introduction

11.19.4 Immunetics Revenue in Infectious Disease Testing Business (2020-2025)

11.19.5 Immunetics Recent Development

11.20 InBios International

11.20.1 InBios International Company Details

11.20.2 InBios International Business Overview

11.20.3 InBios International Infectious Disease Testing Introduction

11.20.4 InBios International Revenue in Infectious Disease Testing Business (2020-2025)

11.20.5 InBios International Recent Development

11.21 Life Technologies

11.21.1 Life Technologies Company Details

11.21.2 Life Technologies Business Overview

11.21.3 Life Technologies Infectious Disease Testing Introduction

11.21.4 Life Technologies Revenue in Infectious Disease Testing Business (2020-2025)

11.21.5 Life Technologies Recent Development

11.22 Maxim Biomedical

11.22.1 Maxim Biomedical Company Details

11.22.2 Maxim Biomedical Business Overview

11.22.3 Maxim Biomedical Infectious Disease Testing Introduction

11.22.4 Maxim Biomedical Revenue in Infectious Disease Testing Business (2020-2025)

11.22.5 Maxim Biomedical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

Table 1. Global Infectious Disease Testing Market Size Growth Rate by Technology (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Immunodiagnostics

Table 3. Key Players of Clinical Microbiology

Table 4. Key Players of PCR

Table 5. Key Players of INAAT

Table 6. Key Players of DNA Sequencing & NGS

Table 7. Key Players of DNA Microarrays

Table 8. Key Players of Other

Table 9. Global Infectious Disease Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Infectious Disease Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Infectious Disease Testing Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global Infectious Disease Testing Market Share by Region (2020-2025)

Table 13. Global Infectious Disease Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global Infectious Disease Testing Market Share by Region (2026-2031)

Table 15. Infectious Disease Testing Market Trends

Table 16. Infectious Disease Testing Market Drivers

Table 17. Infectious Disease Testing Market Challenges

Table 18. Infectious Disease Testing Market Restraints

Table 19. Global Infectious Disease Testing Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global Infectious Disease Testing Market Share by Players (2020-2025)

Table 21. Global Top Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Testing as of 2024)

Table 22. Ranking of Global Top Infectious Disease Testing Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by Infectious Disease Testing Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of Infectious Disease Testing, Headquarters and Area Served

Table 25. Global Key Players of Infectious Disease Testing, Product and Application

Table 26. Global Key Players of Infectious Disease Testing, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Infectious Disease Testing Market Size by Technology (2020-2025) & (US$ Million)

Table 29. Global Infectious Disease Testing Revenue Market Share by Technology (2020-2025)

Table 30. Global Infectious Disease Testing Forecasted Market Size by Technology (2026-2031) & (US$ Million)

Table 31. Global Infectious Disease Testing Revenue Market Share by Technology (2026-2031)

Table 32. Global Infectious Disease Testing Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global Infectious Disease Testing Revenue Market Share by Application (2020-2025)

Table 34. Global Infectious Disease Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global Infectious Disease Testing Revenue Market Share by Application (2026-2031)

Table 36. North America Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America Infectious Disease Testing Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America Infectious Disease Testing Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe Infectious Disease Testing Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe Infectious Disease Testing Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific Infectious Disease Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific Infectious Disease Testing Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific Infectious Disease Testing Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America Infectious Disease Testing Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America Infectious Disease Testing Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa Infectious Disease Testing Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa Infectious Disease Testing Market Size by Country (2026-2031) & (US$ Million)

Table 51. Abbott Diagnostics Company Details

Table 52. Abbott Diagnostics Business Overview

Table 53. Abbott Diagnostics Infectious Disease Testing Product

Table 54. Abbott Diagnostics Revenue in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 55. Abbott Diagnostics Recent Development

Table 56. Abbott Company Details

Table 57. Abbott Business Overview

Table 58. Abbott Infectious Disease Testing Product

Table 59. Abbott Revenue in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 60. Abbott Recent Development

Table 61. Beckman Coulter Diagnostics Company Details

Table 62. Beckman Coulter Diagnostics Business Overview

Table 63. Beckman Coulter Diagnostics Infectious Disease Testing Product

Table 64. Beckman Coulter Diagnostics Revenue in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 65. Beckman Coulter Diagnostics Recent Development

Table 66. Roche Company Details

Table 67. Roche Business Overview

Table 68. Roche Infectious Disease Testing Product

Table 69. Roche Revenue in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 70. Roche Recent Development

Table 71. Siemens Healthcare Company Details

Table 72. Siemens Healthcare Business Overview

Table 73. Siemens Healthcare Infectious Disease Testing Product

Table 74. Siemens Healthcare Revenue in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 75. Siemens Healthcare Recent Development

Table 76. Abaxis Company Details

Table 77. Abaxis Business Overview

Table 78. Abaxis Infectious Disease Testing Product

Table 79. Abaxis Revenue in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 80. Abaxis Recent Development

Table 81. Acon Laboratories Company Details

Table 82. Acon Laboratories Business Overview

Table 83. Acon Laboratories Infectious Disease Testing Product

Table 84. Acon Laboratories Revenue in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 85. Acon Laboratories Recent Development

Table 86. Avioq Company Details

Table 87. Avioq Business Overview

Table 88. Avioq Infectious Disease Testing Product

Table 89. Avioq Revenue in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 90. Avioq Recent Development

Table 91. BD Company Details

Table 92. BD Business Overview

Table 93. BD Infectious Disease Testing Product

Table 94. BD Revenue in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 95. BD Recent Development

Table 96. Bio-Rad Laboratories Company Details

Table 97. Bio-Rad Laboratories Business Overview

Table 98. Bio-Rad Laboratories Infectious Disease Testing Product

Table 99. Bio-Rad Laboratories Revenue in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 100. Bio-Rad Laboratories Recent Development

Table 101. Cavidi Company Details

Table 102. Cavidi Business Overview

Table 103. Cavidi Infectious Disease Testing Product

Table 104. Cavidi Revenue in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 105. Cavidi Recent Development

Table 106. Cepheid Company Details

Table 107. Cepheid Business Overview

Table 108. Cepheid Infectious Disease Testing Product

Table 109. Cepheid Revenue in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 110. Cepheid Recent Development

Table 111. Chembio Diagnostic Systems Company Details

Table 112. Chembio Diagnostic Systems Business Overview

Table 113. Chembio Diagnostic Systems Infectious Disease Testing Product

Table 114. Chembio Diagnostic Systems Revenue in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 115. Chembio Diagnostic Systems Recent Development

Table 116. Clarity Diagnostics Company Details

Table 117. Clarity Diagnostics Business Overview

Table 118. Clarity Diagnostics Infectious Disease Testing Product

Table 119. Clarity Diagnostics Revenue in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 120. Clarity Diagnostics Recent Development

Table 121. EMD Millipore Company Details

Table 122. EMD Millipore Business Overview

Table 123. EMD Millipore Infectious Disease Testing Product

Table 124. EMD Millipore Revenue in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 125. EMD Millipore Recent Development

Table 126. Epitope Diagnostic Company Details

Table 127. Epitope Diagnostic Business Overview

Table 128. Epitope Diagnostic Infectious Disease Testing Product

Table 129. Epitope Diagnostic Revenue in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 130. Epitope Diagnostic Recent Development

Table 131. Gold Standard Diagnostics Company Details

Table 132. Gold Standard Diagnostics Business Overview

Table 133. Gold Standard Diagnostics Infectious Disease Testing Product

Table 134. Gold Standard Diagnostics Revenue in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 135. Gold Standard Diagnostics Recent Development

Table 136. Hologic Company Details

Table 137. Hologic Business Overview

Table 138. Hologic Infectious Disease Testing Product

Table 139. Hologic Revenue in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 140. Hologic Recent Development

Table 141. Immunetics Company Details

Table 142. Immunetics Business Overview

Table 143. Immunetics Infectious Disease Testing Product

Table 144. Immunetics Revenue in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 145. Immunetics Recent Development

Table 146. InBios International Company Details

Table 147. InBios International Business Overview

Table 148. InBios International Infectious Disease Testing Product

Table 149. InBios International Revenue in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 150. InBios International Recent Development

Table 151. Life Technologies Company Details

Table 152. Life Technologies Business Overview

Table 153. Life Technologies Infectious Disease Testing Product

Table 154. Life Technologies Revenue in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 155. Life Technologies Recent Development

Table 156. Maxim Biomedical Company Details

Table 157. Maxim Biomedical Business Overview

Table 158. Maxim Biomedical Infectious Disease Testing Product

Table 159. Maxim Biomedical Revenue in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 160. Maxim Biomedical Recent Development

Table 161. Research Programs/Design for This Report

Table 162. Key Data Information from Secondary Sources

Table 163. Key Data Information from Primary Sources

Table 164. Authors List of This Report

List of Figures

Figure 1. Infectious Disease Testing Picture

Figure 2. Global Infectious Disease Testing Market Size Comparison by Technology (2020-2031) & (US$ Million)

Figure 3. Global Infectious Disease Testing Market Share by Technology: 2024 VS 2031

Figure 4. Immunodiagnostics Features

Figure 5. Clinical Microbiology Features

Figure 6. PCR Features

Figure 7. INAAT Features

Figure 8. DNA Sequencing & NGS Features

Figure 9. DNA Microarrays Features

Figure 10. Other Features

Figure 11. Global Infectious Disease Testing Market Size by Application (2020-2031) & (US$ Million)

Figure 12. Global Infectious Disease Testing Market Share by Application: 2024 VS 2031

Figure 13. Hospitals/Clinical Laboratories Case Studies

Figure 14. Reference Laboratories Case Studies

Figure 15. Academic/Research Institutes Case Studies

Figure 16. Other Case Studies

Figure 17. Infectious Disease Testing Report Years Considered

Figure 18. Global Infectious Disease Testing Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 19. Global Infectious Disease Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 20. Global Infectious Disease Testing Market Share by Region: 2024 VS 2031

Figure 21. Global Infectious Disease Testing Market Share by Players in 2024

Figure 22. Global Top Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Testing as of 2024)

Figure 23. The Top 10 and 5 Players Market Share by Infectious Disease Testing Revenue in 2024

Figure 24. North America Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. North America Infectious Disease Testing Market Share by Country (2020-2031)

Figure 26. United States Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Canada Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Europe Infectious Disease Testing Market Share by Country (2020-2031)

Figure 30. Germany Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. France Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. U.K. Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Italy Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Russia Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Nordic Countries Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific Infectious Disease Testing Market Share by Region (2020-2031)

Figure 38. China Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Japan Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. South Korea Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. India Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Australia Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Latin America Infectious Disease Testing Market Share by Country (2020-2031)

Figure 46. Mexico Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Brazil Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Middle East & Africa Infectious Disease Testing Market Share by Country (2020-2031)

Figure 50. Turkey Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. UAE Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Abbott Diagnostics Revenue Growth Rate in Infectious Disease Testing Business (2020-2025)

Figure 54. Abbott Revenue Growth Rate in Infectious Disease Testing Business (2020-2025)

Figure 55. Beckman Coulter Diagnostics Revenue Growth Rate in Infectious Disease Testing Business (2020-2025)

Figure 56. Roche Revenue Growth Rate in Infectious Disease Testing Business (2020-2025)

Figure 57. Siemens Healthcare Revenue Growth Rate in Infectious Disease Testing Business (2020-2025)

Figure 58. Abaxis Revenue Growth Rate in Infectious Disease Testing Business (2020-2025)

Figure 59. Acon Laboratories Revenue Growth Rate in Infectious Disease Testing Business (2020-2025)

Figure 60. Avioq Revenue Growth Rate in Infectious Disease Testing Business (2020-2025)

Figure 61. BD Revenue Growth Rate in Infectious Disease Testing Business (2020-2025)

Figure 62. Bio-Rad Laboratories Revenue Growth Rate in Infectious Disease Testing Business (2020-2025)

Figure 63. Cavidi Revenue Growth Rate in Infectious Disease Testing Business (2020-2025)

Figure 64. Cepheid Revenue Growth Rate in Infectious Disease Testing Business (2020-2025)

Figure 65. Chembio Diagnostic Systems Revenue Growth Rate in Infectious Disease Testing Business (2020-2025)

Figure 66. Clarity Diagnostics Revenue Growth Rate in Infectious Disease Testing Business (2020-2025)

Figure 67. EMD Millipore Revenue Growth Rate in Infectious Disease Testing Business (2020-2025)

Figure 68. Epitope Diagnostic Revenue Growth Rate in Infectious Disease Testing Business (2020-2025)

Figure 69. Gold Standard Diagnostics Revenue Growth Rate in Infectious Disease Testing Business (2020-2025)

Figure 70. Hologic Revenue Growth Rate in Infectious Disease Testing Business (2020-2025)

Figure 71. Immunetics Revenue Growth Rate in Infectious Disease Testing Business (2020-2025)

Figure 72. InBios International Revenue Growth Rate in Infectious Disease Testing Business (2020-2025)

Figure 73. Life Technologies Revenue Growth Rate in Infectious Disease Testing Business (2020-2025)

Figure 74. Maxim Biomedical Revenue Growth Rate in Infectious Disease Testing Business (2020-2025)

Figure 75. Bottom-up and Top-down Approaches for This Report

Figure 76. Data Triangulation

Figure 77. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Infectious Disease Testing Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Othe-4U222

Global Infectious Disease Testing Market Research Report 2025

FEATURED COMPANIES

Infectious Disease Testing Market Size

Infectious Disease Testing Market

Scope of Infectious Disease Testing Market Report

Chapter Outline

FAQ for this report

How fast is Infectious Disease Testing Market growing?

What is the Infectious Disease Testing Market size in 2031?

Who are the main players in the Infectious Disease Testing Market report?

What are the Application segmentation covered in the Infectious Disease Testing Market report?

FEATURED COMPANIES